OTCMKTS:CZMWY

Carl Zeiss Meditec (CZMWY) Stock Forecast, Price & News

$120.19

+2.73 (+2.32%)

(As of 06/2/2023 ET)

Compare

Today's Range: $118.00
▼
$120.48
50-Day Range: $112.19
▼
$144.66
52-Week Range: $99.29
▼
$153.84

Volume: 808 shs
Average Volume: 1,030 shs
Market Capitalization: N/A

P/E Ratio: 130.64
Dividend Yield: 0.25%
Price Target: $167.00

Profile Analyst Ratings Chart Competitors Dividend Headlines Short Interest

Carl Zeiss Meditec MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 39.0% Upside
$167.00 Price Target
Short Interest: Healthy
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.71 out of 5 stars

3.3

Analyst's Opinion

Consensus Rating
Carl Zeiss Meditec has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $167.00, Carl Zeiss Meditec has a forecasted upside of 39.0% from its current price of $120.19.
Amount of Analyst Coverage
Carl Zeiss Meditec has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
Short Interest Ratio / Days to Cover
Carl Zeiss Meditec has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Carl Zeiss Meditec has recently decreased by 30.00%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
Carl Zeiss Meditec pays a meaningful dividend of 1.36%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Carl Zeiss Meditec does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Carl Zeiss Meditec is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CZMWY.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Carl Zeiss Meditec this week, compared to 0 articles on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Carl Zeiss Meditec insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.10% of the stock of Carl Zeiss Meditec is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Carl Zeiss Meditec is 130.64, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 126.71.
Price to Earnings Ratio vs. Sector
The P/E ratio of Carl Zeiss Meditec is 130.64, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 92.14.

See Top Rated MarketRank™ Stocks Here

About Carl Zeiss Meditec (OTCMKTS:CZMWY) Stock

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on July 2002 and is headquartered in Jena, Germany.

Receive CZMWY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

CZMWY Stock News Headlines

May 29, 2023 | americanbankingnews.com

Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Sees Large Decrease in Short Interest

April 12, 2023 | finance.yahoo.com

Institutions own 22% of Carl Zeiss Meditec AG (ETR:AFX) shares but private companies control 59% of the company

June 4, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

February 19, 2023 | finance.yahoo.com

Carl Zeiss Meditec First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags

February 3, 2023 | markets.businessinsider.com

EQS-AFR: Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

January 20, 2023 | finance.yahoo.com

Carl Zeiss Meditec (ETR:AFX) Is Increasing Its Dividend To €1.10

January 12, 2023 | finance.yahoo.com

Carl Zeiss Meditec (ETR:AFX) Might Have The Makings Of A Multi-Bagger

December 28, 2022 | finance.yahoo.com

Carl Zeiss Meditec AG's (ETR:AFX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

June 4, 2023 | Vantage Point (Ad)

We Called (ARWR) In Advance, Which Stocks Are Next?

Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE.

December 12, 2022 | finance.yahoo.com

Carl Zeiss Meditec (ETR:AFX) Will Pay A Larger Dividend Than Last Year At €1.10

December 9, 2022 | technews.tmcnet.com

ZEISS Academy Africa inaugurated

November 12, 2022 | seekingalpha.com

CZMWY Carl Zeiss Meditec AG

May 14, 2022 | markets.businessinsider.com

What Wall Street expects from Carl Zeiss Meditec's earnings

February 13, 2022 | uk.finance.yahoo.com

Carl Zeiss Meditec achieves further growth in first quarter of 2021/22

February 13, 2022 | markets.businessinsider.com

Carl Zeiss Meditec earnings preview: what Wall Street is expecting

December 12, 2021 | uk.finance.yahoo.com

Record revenue for Carl Zeiss Meditec in fiscal year 2020/21

December 10, 2021 | seekingalpha.com

Carl Zeiss Meditec AG 2021 Q1 - Results - Earnings Call Presentation

October 2, 2021 | uk.finance.yahoo.com

Change to Executive Board of Carl Zeiss Meditec AG

September 30, 2021 | uk.finance.yahoo.com

Leadership Change in the Executive Board of Carl Zeiss Meditec AG

September 18, 2021 | wsj.com

Carl Zeiss Meditec AG ADR

July 19, 2021 | investing.com

Germany stocks lower at close of trade; DAX down 2.62%

July 17, 2021 | investing.com

Carl Zeiss Meditec AG ADR (CZMWY)

July 15, 2021 | marketwatch.com

Ophthalmic Devices Market to See Promising Growth Ahead| Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A.

July 9, 2021 | investing.com

Germany stocks higher at close of trade; DAX up 1.73%

July 8, 2021 | marketwatch.com

Near Infrared Imaging/NIR Market Recent Trends, In-depth Analysis, Size and Forecast To 2027

July 7, 2021 | finance.yahoo.com

CARL ZEISS MEDITEC AG (CZMWY) stock forecast and price target

July 1, 2021 | markets.businessinsider.com

Global Ophthalmic Lasers Market to Reach $1.2 Billion by 2026

See More Headlines

CZMWY Price History

30 days | 90 days | 365 days | Advanced Chart

CZMWY Company Calendar

Ex-Dividend for 4/11 Dividend: 3/23/2023
Dividend Payable: 4/11/2023
Today: 6/04/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CZMWY
CUSIP: N/A
CIK: N/A
Web: www.zeiss.com
Phone: 493641220115
Fax: N/A
Employees: 3,531
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $167.00
High Stock Price Forecast: $167.00
Low Stock Price Forecast: $167.00
Forecasted Upside/Downside: +39.0%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 130.64
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Markus Weber
Chairman-Management Board

Justus Felix Wehmer
Chief Financial Officer

Sebastian Frericks
Director-Investor Relations

Key Competitors

View All Competitors

CZMWY Stock - Frequently Asked Questions

Should I buy or sell Carl Zeiss Meditec stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Carl Zeiss Meditec in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CZMWY shares.
View CZMWY analyst ratings or view top-rated stocks.
What is Carl Zeiss Meditec's stock price forecast for 2023?: 2 brokers have issued 12-month price objectives for Carl Zeiss Meditec's shares. Their CZMWY share price forecasts range from $167.00 to $167.00. On average, they expect the company's stock price to reach $167.00 in the next twelve months. This suggests a possible upside of 39.0% from the stock's current price.
View analysts price targets for CZMWY or view top-rated stocks among Wall Street analysts.
How have CZMWY shares performed in 2023?: Carl Zeiss Meditec's stock was trading at $126.09 at the beginning of the year. Since then, CZMWY stock has decreased by 4.7% and is now trading at $120.1850.
View the best growth stocks for 2023 here.
Are investors shorting Carl Zeiss Meditec?: Carl Zeiss Meditec saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 700 shares, a decrease of 30.0% from the April 30th total of 1,000 shares. Based on an average daily volume of 5,000 shares, the short-interest ratio is currently 0.1 days.
View Carl Zeiss Meditec's Short Interest.
How often does Carl Zeiss Meditec pay dividends? What is the dividend yield for Carl Zeiss Meditec?: Carl Zeiss Meditec declared a dividend on Friday, March 17th. Investors of record on Friday, March 24th will be paid a dividend of $0.8144 per share on Tuesday, April 11th. This represents a dividend yield of 0.56%. The ex-dividend date is Thursday, March 23rd. This is an increase from the stock's previous dividend of $0.68.
Read our dividend analysis for CZMWY.

Is Carl Zeiss Meditec a good dividend stock?: Carl Zeiss Meditec (OTCMKTS:CZMWY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.36%. The dividend payout ratio is 32.64%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CZMWY.
What is Carl Zeiss Meditec's stock symbol?: Carl Zeiss Meditec trades on the OTCMKTS under the ticker symbol "CZMWY."
How do I buy shares of Carl Zeiss Meditec?: Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Carl Zeiss Meditec's stock price today?: One share of CZMWY stock can currently be purchased for approximately $120.19.
How many employees does Carl Zeiss Meditec have?: The company employs 3,531 workers across the globe.
How can I contact Carl Zeiss Meditec?: Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, Jena, Thueringen 07745. The official website for the company is www.zeiss.com. The company can be reached via phone at 493641220115.

This page (OTCMKTS:CZMWY) was last updated on 6/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial